Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BTSG NASDAQ:GH NASDAQ:RDNT NASDAQ:SGRY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBTSGBrightSpring Health Services$27.23-2.7%$23.19$14.03▼$28.43$4.82B2.272.18 million shs2.95 million shsGHGuardant Health$57.67-3.4%$54.89$20.14▼$68.00$7.19B1.462.40 million shs4.46 million shsRDNTRadNet$75.54-2.2%$65.78$45.00▼$93.65$5.81B1.54809,996 shs505,024 shsSGRYSurgery Partners$21.88+0.5%$22.39$18.87▼$33.37$2.81B1.761.40 million shs656,156 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBTSGBrightSpring Health Services+1.38%+3.25%+12.51%+23.75%+86.41%GHGuardant Health-0.10%+7.80%-2.74%+19.68%+154.24%RDNTRadNet+2.12%+3.87%+10.19%+37.68%+8.64%SGRYSurgery Partners-0.46%+0.97%-7.91%+0.28%-32.66%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBTSGBrightSpring Health Services$27.23-2.7%$23.19$14.03▼$28.43$4.82B2.272.18 million shs2.95 million shsGHGuardant Health$57.67-3.4%$54.89$20.14▼$68.00$7.19B1.462.40 million shs4.46 million shsRDNTRadNet$75.54-2.2%$65.78$45.00▼$93.65$5.81B1.54809,996 shs505,024 shsSGRYSurgery Partners$21.88+0.5%$22.39$18.87▼$33.37$2.81B1.761.40 million shs656,156 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBTSGBrightSpring Health Services+1.38%+3.25%+12.51%+23.75%+86.41%GHGuardant Health-0.10%+7.80%-2.74%+19.68%+154.24%RDNTRadNet+2.12%+3.87%+10.19%+37.68%+8.64%SGRYSurgery Partners-0.46%+0.97%-7.91%+0.28%-32.66%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBTSGBrightSpring Health Services 2.92Moderate Buy$27.10-0.48% DownsideGHGuardant Health 3.05Buy$59.002.31% UpsideRDNTRadNet 3.25Buy$76.801.67% UpsideSGRYSurgery Partners 2.67Moderate Buy$32.8850.25% UpsideCurrent Analyst Ratings BreakdownLatest SGRY, GH, RDNT, and BTSG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/22/2025GHGuardant HealthWells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight$72.009/22/2025GHGuardant HealthWells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight$72.009/22/2025GHGuardant HealthBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$70.009/18/2025SGRYSurgery PartnersJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageNeutral$27.009/10/2025BTSGBrightSpring Health ServicesBank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$27.50 ➝ $31.009/8/2025BTSGBrightSpring Health ServicesDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy$30.009/4/2025GHGuardant HealthBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$65.00 ➝ $70.009/3/2025RDNTRadNetBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$60.00 ➝ $79.009/3/2025RDNTRadNetTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$74.00 ➝ $81.008/18/2025RDNTRadNetZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold8/13/2025RDNTRadNetRaymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingStrong-Buy$66.00 ➝ $75.00(Data available from 9/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBTSGBrightSpring Health Services$11.27B0.43$1.85 per share14.75$9.46 per share2.88GHGuardant Health$739.02M9.73N/AN/A($1.13) per share-51.04RDNTRadNet$1.91B3.05$3.48 per share21.72$15.31 per share4.93SGRYSurgery Partners$3.24B0.87$1.87 per share11.68$25.15 per share0.87Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBTSGBrightSpring Health Services-$18.06M$0.3187.8433.210.460.55%9.29%2.64%11/7/2025 (Estimated)GHGuardant Health-$436.37M-$3.35N/AN/AN/A-49.93%N/A-28.95%11/5/2025 (Estimated)RDNTRadNet$2.79M-$0.20N/A142.53N/A-0.78%2.41%0.82%11/10/2025 (Estimated)SGRYSurgery Partners-$168.10M-$1.43N/A27.01N/A-5.57%2.51%1.01%11/11/2025 (Estimated)Latest SGRY, GH, RDNT, and BTSG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/10/2025Q2 2025RDNTRadNet$0.17$0.31+$0.14$0.43$488.06 million$498.23 million8/5/2025Q2 2025SGRYSurgery Partners$0.16$0.17+$0.01-$0.02$816.96 million$826.20 million8/1/2025Q2 2025BTSGBrightSpring Health Services$0.19$0.22+$0.03$0.13$2.99 billion$3.15 billion7/30/2025Q2 2025GHGuardant Health-$0.52-$0.44+$0.08-$0.80$211.19 million$232.09 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBTSGBrightSpring Health ServicesN/AN/AN/AN/AN/AGHGuardant HealthN/AN/AN/AN/AN/ARDNTRadNetN/AN/AN/AN/AN/ASGRYSurgery PartnersN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBTSGBrightSpring Health Services1.431.761.34GHGuardant HealthN/A3.713.35RDNTRadNet0.912.002.00SGRYSurgery Partners1.101.931.78Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBTSGBrightSpring Health ServicesN/AGHGuardant Health92.60%RDNTRadNet77.90%SGRYSurgery PartnersN/AInsider OwnershipCompanyInsider OwnershipBTSGBrightSpring Health Services3.40%GHGuardant Health6.10%RDNTRadNet5.60%SGRYSurgery Partners2.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBTSGBrightSpring Health Services35,000177.15 million171.13 millionOptionableGHGuardant Health2,021124.71 million117.10 millionNot OptionableRDNTRadNet11,02176.92 million72.61 millionOptionableSGRYSurgery Partners15,000128.21 million124.75 millionOptionableSGRY, GH, RDNT, and BTSG HeadlinesRecent News About These CompaniesVoya Investment Management LLC Sells 39,791 Shares of Surgery Partners, Inc. $SGRYSeptember 22 at 3:08 AM | marketbeat.comSurgery Partners (NASDAQ:SGRY) Coverage Initiated at JPMorgan Chase & Co.September 20, 2025 | americanbankingnews.comJPMorgan Chase & Co. Reiterates Neutral Rating for Surgery Partners (NASDAQ:SGRY)September 19, 2025 | marketbeat.comSurgery Partners assumed with a Neutral at JPMorganSeptember 18, 2025 | msn.comE. Ohman J or Asset Management AB Cuts Stock Holdings in Surgery Partners, Inc. $SGRYSeptember 16, 2025 | marketbeat.comWesbanco Bank Inc. Boosts Stake in Surgery Partners, Inc. $SGRYSeptember 16, 2025 | marketbeat.comSurgery Partners, Inc. (NASDAQ:SGRY) Given Average Rating of "Moderate Buy" by AnalystsSeptember 16, 2025 | marketbeat.comSurgery Partners, Inc. (NASDAQ:SGRY) Given Average Recommendation of "Moderate Buy" by AnalystsSeptember 15, 2025 | americanbankingnews.comHow Surgery Partners’ $1.38 Billion Refinancing May Shape Stability and Growth Plans for SGRY InvestorsSeptember 14, 2025 | finance.yahoo.comWoodline Partners LP Purchases Shares of 525,400 Surgery Partners, Inc. $SGRYSeptember 14, 2025 | marketbeat.com42,803 Shares in Surgery Partners, Inc. $SGRY Bought by Bayforest Capital LtdSeptember 11, 2025 | marketbeat.comHarrison Bane Sells 9,339 Shares of Surgery Partners (NASDAQ:SGRY) StockSeptember 10, 2025 | marketbeat.comCaxton Associates LLP Makes New Investment in Surgery Partners, Inc. $SGRYSeptember 10, 2025 | marketbeat.comTwin Securities Inc. Makes New $7.84 Million Investment in Surgery Partners, Inc. $SGRYSeptember 9, 2025 | marketbeat.comSurgery Partners (NASDAQ:SGRY) Insider Sells $209,940.72 in StockSeptember 9, 2025 | insidertrades.comSurgery Partners: Deleveraging Needs To Be The PrioritySeptember 8, 2025 | seekingalpha.comPentwater Capital Management LP Has $65.12 Million Holdings in Surgery Partners, Inc. $SGRYSeptember 8, 2025 | marketbeat.comSurgery Partners, Inc. $SGRY Stock Holdings Decreased by Hsbc Holdings PLCSeptember 6, 2025 | marketbeat.comSurgery Partners, Inc. $SGRY Shares Sold by Ardsley Advisory Partners LPSeptember 5, 2025 | marketbeat.com40,000 Shares in Surgery Partners, Inc. $SGRY Acquired by ADAR1 Capital Management LLCSeptember 4, 2025 | marketbeat.comJump Financial LLC Makes New $363,000 Investment in Surgery Partners, Inc. $SGRYSeptember 4, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesNVIDIA Stock Could Pull Back in September, But Don’t Bet on ItBy Thomas Hughes | August 28, 2025Snowflake’s Snowballing Business and Robust Stock Price OutlookBy Thomas Hughes | August 28, 20253 Tariff-Proof Retailers Making New All-time HighsBy Dan Schmidt | September 1, 2025Amazon’s Chart Just Flashed a Pennant Pattern—Here’s What to DoBy Sam Quirke | August 27, 2025Why Datavault May Be the Penny AI Stock Investors Have Waited ForBy Nathan Reiff | September 22, 2025SGRY, GH, RDNT, and BTSG Company DescriptionsBrightSpring Health Services NASDAQ:BTSG$27.23 -0.75 (-2.68%) Closing price 04:00 PM EasternExtended Trading$27.21 -0.02 (-0.07%) As of 05:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.Guardant Health NASDAQ:GH$57.67 -2.05 (-3.43%) Closing price 04:00 PM EasternExtended Trading$57.62 -0.05 (-0.09%) As of 05:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.RadNet NASDAQ:RDNT$75.54 -1.70 (-2.20%) Closing price 04:00 PM EasternExtended Trading$76.05 +0.51 (+0.68%) As of 05:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.Surgery Partners NASDAQ:SGRY$21.88 +0.11 (+0.51%) Closing price 04:00 PM EasternExtended Trading$21.88 +0.01 (+0.02%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Qualcomm’s RSI Just Hit Its High of the Year—Why That’s Bullish 2 Ways to Trade Amazon Ahead of October’s Prime Day AutoZone Pulls Into a Buy-the-Dip Opportunity Rocket Lab’s Bullish Case Remains Intact Despite Recent Offering Broadcom Price Targets Just Reached Above $400 for the First Time Replace Your Fixed Income With This Dividend ETF These 3 Mega-Cap Giants Just Increased Dividends by 7% or More Ford Set to Outpace GM With Tariff Tailwinds and EPS Momentum Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
